LD-2 disclosure · 1st Quarter - Report
SHIRE PHARMACEUTICALS LLC
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Pharmaceutical Company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing
LobbyistsENGEL BURNS · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
ADHD Awareness *Drug Values -DEA processes and re-exportation -FDA Funding -Medicaid rare disease patient access to therapy Patient access to therapy, including Medicaid, Medicare, and insurance. -Orphan Drug Act regulations -Expanded Access -Rare Disease awareness -Right to Try legislation (S. 204, H.R. 878, and H.R. 2368) -Newborn Screening
LobbyistsJED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Orphan drug tax credit HR 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (Tax Cuts and Jobs Act)
LobbyistsJED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES